Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Change in Cash (2024 - 2026)

Hinge Health recorded quarterly Change in Cash of -$21.7 million in Q1 2026, up 59.35% quarter-over-quarter from -$53.3 million in Q4 2025, and down 76.26% year-over-year from -$91.4 million in Q1 2025.

Hinge Health's Change in Cash history runs 3 years deep, the most recent figure standing at -$21.7 million for Q1 2026.

  • In Q1 2026, Change in Cash fell 76.26% year-over-year to -$21.7 million; the TTM figure through Mar 2026 stood at -$102.2 million (changed N/A YoY), while the FY2025 annual figure was -$92.8 million, down 242.51% from the prior year.
  • Change in Cash came in at -$21.7 million for Q1 2026 at Hinge Health, up from -$53.3 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $32.9 million in Q4 2024 to a low of -$53.3 million in Q4 2025.
  • A 3-year average of -$7.2 million and a median of -$12.3 million in 2025 frame the typical range for Change in Cash.
  • On a YoY basis, Change in Cash climbed as much as 21.79% in 2025 and fell as far as 262.2% in 2025.
  • Hinge Health's Change in Cash stood at $32.9 million in 2024, then plunged by 262.2% to -$53.3 million in 2025, then soared by 59.35% to -$21.7 million in 2026.
  • According to Business Quant data, Change in Cash over the past three periods registered -$21.7 million, -$53.3 million, and $24.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -238.90 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 800.32 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn -53.56 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -21.68 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 154.34 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn -14.11 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 16.32 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -60.16 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 39.93 Mn
10 Teladoc Health 1.42 Bn 672.39 Mn 562.57 Mn -29.46 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -21.68 Mn
Dec 31, 2025 -53.35 Mn
Sep 30, 2025 24.17 Mn
Jun 30, 2025 -51.31 Mn
Mar 31, 2025 -12.30 Mn
Dec 31, 2024 32.89 Mn
Sep 30, 2024 30.91 Mn